Topic
drug-withdrawal
1 stories related to this topic, newest first.
Substrate placeholder — needs reviewworld28 days agoFraming55Framing risk55/100Rewrite centers on FDA's safety concerns and data issues in the lede, with balanced Amgen response but slight emphasis on negative aspects.Click to jump to full framing analysis
FDA Proposes Revoking Approval of Amgen's Tavneos
The U.S. Food and Drug Administration proposed withdrawing approval for Amgen's drug Tavneos on April 28, 2026, citing lack of proven effectiveness and false statements in the original application. The agency reported 76 cases of drug-induced liver injury linked to the drug, incl…